Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy. This side effect has only once previously been reported with the nitrosourea group of compounds.
D002330:Carmustine / Q000009:adverse effects*; D002528:Cerebellar Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D008527:Medulloblastoma / Q000188:drug therapy*; D011018:Pneumonia, Pneumococcal / Q000150:complications; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000150:complications / Q000473:pathology
D002330:Carmustine